Repurposing tocilizumab in scleroderma patients may prevent early lung disease
Research led by Michigan Medicine's Scleroderma Program and published in Arthritis & Rheumatology found that tocilizumab, a FDA-approved anti-inflammatory drug used to combat rheumatoid arthritis, can prevent lung disease ...
Mar 31, 2021
0
14